Clinical Trial Update: Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating percutaneous ethanol formulations (96% gel and 98% solution) for systemic and local diffusion, with PK/PD and clinical outcomes in cong…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Venous Malformation

Drugs mentioned

• Ethanol 96% gel (percutaneous formulation) (ethanol)
• Ethanol 98% solution (percutaneous formulation) (ethanol)

Snippet

Sponsor: Orfagen | Conditions: Congenital Venous Malformation | Phase 2 | Status: COMPLETED | Results posted: 2014-12-12